Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shenzhen Bowa Pharmaceutical, known as Bowa Pharma or Bowapharm, is a specialized pharmaceutical company based in Shenzhen, China, focusing on the research, development, and production of chemical drugs. Since its inception in 2004, the company has established a significant presence in the fields of gastroenterology, cardiovascular health, and anti-infective therapies. Bowa Pharma's commercial portfolio includes widely recognized products such as Rabeprazole Sodium and Amlodipine Besylate, manufactured in compliance with stringent Good Manufacturing Practice (GMP) standards. The company leverages its advanced R&D capabilities to develop high-quality generic medications and improved formulations that address unmet medical needs. With a commitment to technological innovation, Bowa Pharma serves both the domestic Chinese market and international partners. Their facilities are equipped for large-scale small molecule synthesis and finished dosage form production.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bowapharm.